| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fishman Peter L. | SVP, CFO | C/O AMARIN PHARMA, INC., 440 US HIGHWAY 22, BRIDGEWATER | /s/ Jonathan Provoost, by power of attorney | 04 Aug 2025 | 0002042862 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMRN | American Depositary Share | Options Exercise | +312 | +8.1% | 4,148 | 01 Aug 2025 | Direct | F1, F2, F3 | ||
| transaction | AMRN | American Depositary Share | Tax liability | $2,323 | -160 | -3.9% | $14.52 | 3,988 | 01 Aug 2025 | Direct | F1, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMRN | Restricted Stock Unit | Award | $0 | +312 | +31200% | $0.000000 | 313 | 01 Aug 2025 | American Depositary Shares | 312 | $0.000000 | Direct | F1, F2, F3, F5 |
| Id | Content |
|---|---|
| F1 | Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. |
| F2 | On August 8, 2022, the Reporting Person was granted 1,250 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in four equal installments on each of August 1, 2023, August 1, 2024, August 1, 2025, and August 1, 2026. |
| F3 | Not applicable. |
| F4 | Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. |
| F5 | Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. |